Melanoma Focus Virtual Regional Meeting 2024

Friday 17th May 2024

Organised by: Dr Ricky Frazer, Consulant Oncologist, Velindre Cancer Centre, Cardiff

Location: Virtual

Registration for this event is now open

Friday, 17th May 20249:00 am – 5:00 pm

The early bird rate for this event ends 21st April 2024. Please also submit your poster abstracts by 21st April 2024 (250 words maximum) to jenn@melanomafocus.org

The Royal College of Surgeons of England has awarded up to 6 CPD points. Applications have also been sent to The Royal Colleges of Physicians of the United Kingdom and The British Association of Plastic, Reconstructive and Aesthetic Surgeons.

If you are unsure about your membership, please email memberships@melanomafocus.org

The programme for this event will be shared soon!

Register Today!

2024 EARLY-BIRD REGISTRATION

Delegate Type:Earlybird
(ends 21/04/24)
MembersOpen Form(£35-£99)
Non-MembersOpen Form(£55-139)
IndustryOpen Form(£219)

PROGRAMME

09:00-09:15

Welcome/Introductions (Dr Mark Harries / Susanna Daniels/Dr Ricky Frazer)

09:15-10:15

Session 1:  Melanoma for 2030

Chair: Dr Rebecca Lee, Senior Lecturer University of Manchester and Francis Crick/UCL; Consultant Medical Oncologist, The Christie NHS Foundation Trust

09:15-09:45

Melanoma for 2030:  A horizon scan of future options and how do we get ourselves ready

Dr Heather Shaw, Consultant Medical Oncologist, Mount Vernon Cancer Centre and UCLH

09:45-10:00

Update on UK Skin Cancer Clinical Trials Group 

Dr Brent O’Carrigan, Consultant Medical Oncologist, Cambridge University Hospitals NHS Trust

10:00-10:15

Q&A

10:15-10:25

Comfort Break

10:25-11:25

Session 2:  A Novel Complex Melanoma MDT ‘Diagnosis, Staging and Response Assessment’

Chairs: Dr Aisling Butler, Consultant Radiologist, Velindre Cancer Centre & – Miss Sarah Hemington Gorse, Consultant Plastic Surgeon, Swansea

Panel:

– Dr Satish Kumar, Consultant Medical Oncologist, Velindre Cancer Centre

– Michelle Norton CNS, Velindre Cancer Centre

– Dr Jo Ocen, Consultant Medical Oncologist, Velindre Cancer Centre

– Dr Allie Shipp, Consultant Medical Oncologist, Velindre Cancer Centre

– Dr Ricky Frazer, Consultant Medical Oncologist, Velindre Cancer Centre

11:25-13:30

Pharma Exhibition Area / Posters

11:30-12:30

PIERRE FABRE SPONSORED SYMPOSIUM 

Management of challenging BRAF mutant metastatic melanoma: a focus on the management of patients with brain metastases

13:30-15:05

Session 3: Optimising Checkpoint Inhibitors in Melanoma

Chair: Dr Anna Olsson-Brown, Consultant Medical Oncologist, Sussex Cancer Centre

13:30-14:00

The role of immunotherapy in patients with complex comorbidities       

Professor Jeff Weber, Interim Director, Laura and Isaac Perlmutter Cancer Center; Professor of Medicine and Perlmutter Professor of Oncology, NYU-Grossman School of Medicine

14:00-14:25

Cardiotoxicity and Baseline Testing

-Dr Rebecca Dobson, Consultant Cardiologist, Liverpool Heart and Chest Hospital NHS Foundation Trust

-Dr Clare Barlow, Consultant Medical Oncologist and Immunotherapy Lead, Somerset NHS Foundation Trust

14:25-14:45

Supporting professionals in the IO Space

Dr Kate Young, Consultant Medical Oncologist, The Royal Marsden Hospital NHS Foundation Trust

14:45-15:05

Q&A

15:05-15:10

Comfort Break

15:10-16:05

Session 4: Supporting Patients in 2024
Chair: Dr Heather Shaw, Consultant Medical Oncologist, Mount Vernon Cancer Centre and UCLH

15:10-15:35

What matters to patients in melanoma diagnosis and management?                             

-Imogen Cheese, Founder of the Melanoma Patient Conference

-Imogen Llewellyn, Stage 4 patient

15:35-15:50

Supporting the patient to support themselves – the PRIMM study       

Dr Veronique Bataille, Consultant Dermatologist, West Hertfordshire Teaching Hospitals NHS Trust and Kings College London

15:50-16:05

Q&A

16:05-16:15

Comfort Break

16:15-17:25

Session 5:  MDT:  Past Present and Future

Chair: Dr Ricky Frazer, Consultant Medical Oncologist, Velindre Cancer Centre

Panel:

– Professor James Larkin, Consultant Medical Oncologist, Royal Marsden Hospital NHS Foundation Trust

– Professor Jeff Weber, Interim Director, Laura and Isaac Perlmutter Cancer Center; Professor of Medicine and Perlmutter Professor of Oncology, NYU-Grossman School of Medicine

– Professor Rowan Pritchard-Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System

– Dr Chris Herbert, Consultant Clinical Oncologist, University Hospitals Bristol NHS Foundation Trust

-Dr Anna Olsson-Brown, Consultant Medical Oncologist, Sussex Cancer Centre

17:25-17:30

Concluding Remarks and Close

Dr Mark Harries, Chairman Melanoma Focus, Dr Ricky Frazer, Organiser